ロード中...
Recent advances in siRNA delivery mediated by lipid-based nanoparticles
Small interfering RNA (siRNA) has been expected to be a unique pharmaceutic for the treatment of broad-spectrum intractable diseases. However, its unfavorable properties such as easy degradation in the blood and negative-charge density are still a formidable barrier for clinical use. For disruption...
保存先:
| 出版年: | Adv Drug Deliv Rev |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier B.V.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7406478/ https://ncbi.nlm.nih.gov/pubmed/32768564 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.addr.2020.07.022 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|